Justin Van Fleet
CIK: 0002080067
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NXL
Nexalin Technology, Inc.
Officer
Discretionary Trading P&L
Holdings
About Van Fleet Justin
Van Fleet Justin (SEC CIK 0002080067) files insider reports with the SEC as CFO of Nexalin Technology, Inc. (NXL).
Signal8 holds 2 ownership filings by Van Fleet Justin (1 Form 3, 1 Form 4), filed between Aug 7, 2025 and Dec 23, 2025. Those filings report 1 transaction, the latest on Dec 19, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Van Fleet Justin's filings is in HOUSTON, TX.
Recent filings by Van Fleet Justin
- Dec 19, 2025: Grant or award of NXL derivative securities (Form 4, code A).
Other insiders filing for Nexalin Technology, Inc. (NXL)
- White Mark, President and CEO
- Owens David, Chief Medical Officer
- Shelton Carolyn Hamby, Senior VP
- Hu Ben, Director
- Kazden Alan, Director
- OSSER LEONARD, 10% Owner